Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
₹3 L
Closing Date
12 Oct 2026, 9:00 am3d left
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
COMMANDANT
COMMAND HOSPITAL,CC,LUCKNOW
PROCUREMENT OF HOSPITAL MEDICINE
2026_ARMY_793055_1
MSPC/13/LP-190/2026-27
Limited
Drugs and Pharmaceutical Products
Buy
7 days
COMMAND HOSPITAL, CC
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
9 Oct 2026
9 Oct 2026
12 Oct 2026
9 Oct 2026
12 Oct 2026
9 Oct 2026
9 Oct 2026 - 12 Oct 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1.01 | Tirzepatide 7.5 mg Inj Multidose PFP | 1 | PFS | - | - |
| 2.01 | Inj Secukinumab 150 mg/ml | 75 | VIAL | - | - |
| 3.01 | Polyglycolic Acid Coatcol Braided Fast Absorbable Surgical Suture size 2/0 Round Body+Cutting needle 140 cm BOX OF 12 | 110 | BOX | - | - |
| 4.01 | Dextrose 50%, 25ml Inj | 1,870 | AMP | - | - |
| 5.01 | Adenosine 3 mg/ml, 2 ml Inj | 370 | VIAL/AMP | - | - |
| 6.01 | Artesunate 60 mg Inj | 1,500 | VIAL | - | - |
| 7.01 | Primaquine (7.5mg base) Tab | 720 | NO | - | - |
| 8.01 | Olanzapine LA 210 mg/ml Inj | 6 | VIAL | - | - |
| 9.01 | Olanzapine LA 405 mg/ml Inj | 6 | VIAL | - | - |
| 10.01 | Methylcobalamine 1500 mcg Tab | 1,25,000 | NO | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.47 MB
RFPLP190.pdf
Tender Documents • 1.06 MB
BOQ_889329.xls
BOQ • 0.45 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .